ArticleJournal of oral biology and craniofacial research
Biocompatibility and odontogenic potential of an indigenous apitherapeutic pulp capping agent: A comparative in vitro analysis using hDPSCs.
Article in Journal of oral biology and craniofacial research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: This study aimed to evaluate the cytocompatibility and odonto-inductive potential of an indigenously developed apitherapeutic pulp capping agent Api-Therapeutic Pulp Guard (ATPG) by assessing cell viability and dentinogenic gene expression using human dental pulp stem cells (hDPSCs). Materials and methods: hDPSCs were exposed to eluates of ATPG and compared with calcium hydroxide (RC-Cal) and control. MTT assay was used to assess cell viability, LIVE/DEAD staining was performed using calcein-AM and ethidium homodimer, and quantitative real-time PCR (qPCR) evaluated DSPP gene expression. This comprehensive approach provided complementary insights into cell metabolic activity, membrane integrity, and odontogenic potential of the test materials. Results: ATPG exhibited high cell viability (96.52 %), significantly greater than calcium hydroxide (84.25 %) ( Conclusion: The ATPG formulation demonstrated superior biocompatibility and odontogenic potential compared to conventional calcium hydroxide, underscoring its promise for translation in regenerative endodontic therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.